Aspira Women's Health Inc.
AWHL· OTC
AWHLAspira Women's Health Inc.
Released Aug 12, 2024, after the close
10-Q filed Aug 13, 2024, 44 days after period end · 0000950170-24-096220
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $2.42M | $2.49M | $2.07M | $1.80M |
| Net Income | -$3.53M | -$2.32M | -$8.24M | -$7.07M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.28 |
| -$0.28 |
| -$1.10 |
| -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
